A newly discovered biomarker can predict cancer aggressiveness
Using a new technology and computational method, researchers from Fred Hutch Cancer Center and The University of Texas MD Anderson Cancer Center have uncovered a biomarker capable of accurately predicting outcomes in meningioma brain tumors and breast cancers.
UI researchers develop new imaging tool aiming to lower re-operation rates after cancer surgery
The Margin Diagnostics (MarginDx) project combined imaging technology and other tools to assist doctors during surgeries and ensure all tumor cells are removed. The system collects an “optical biopsy,” similar to an ultrasound, but uses light instead.
Light-activated compound offers hope for overcoming drug resistance in cancer treatment
A research team affiliated with UNIST has unveiled an innovative technology to eliminate drug-resistant cancer cells using light. Professors Tae-Hyuk Kwon and Duyoung Min from the Department of Chemistry at UNIST, alongside Professor Taiho Park from POSTECH, have created a photoreactive compound capable of suppressing autophagy in cancer cells—one of the key mechanisms contributing to resistance against anticancer therapies.
Huntsman Cancer Institute leads the way with advanced robotic surgery technology
Huntsman Cancer Institute at the University of Utah (the U) proudly announces the addition of two da Vinci 5 robotic surgical systems.
Can robots like Roxy revolutionise cancer surgery?
n operating theatre D at Glasgow’s Royal Infirmary, gynaecological oncologist Dr Kevin Burton is directing four arms of a robot, affectionately named Roxy.
Best-selling Apple product ‘has been exposing us to CANCER’
Apple has been accused of exposing users to cancer in a new lawsuit that claims one of tech giant’s best-selling products contain high levels of cancer-causing ‘forever chemicals.’
